Raymond James Financial Services Advisors, Inc. Cor Medix Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 80,499 shares of CRMD stock, worth $733,345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,499
Previous 82,945
2.95%
Holding current value
$733,345
Previous $359,000
81.06%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CRMD
# of Institutions
139Shares Held
21.7MCall Options Held
599KPut Options Held
401K-
Black Rock Inc. New York, NY3.55MShares$32.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.38MShares$30.8 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl2.87MShares$26.2 Million0.14% of portfolio
-
State Street Corp Boston, MA1.45MShares$13.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.39MShares$12.7 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $375M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...